GlassScriptPhysician profile
Jeffrey P Norris
NPI 1508849142
$14,362.72
in general payments reported to CMS, 2019-2025
57 companies · $2,535 in 2025
The $2,535 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,489 · 2020: $774 · 2021: $1,671 · 2022: $2,011 · 2023: $1,665 · 2024: $4,218 · 2025: $2,535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,124 · Consulting Fee: $2,200 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,123.71 |
| Consulting Fee | $2,200.00 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $2,869.61 | 2019-2025 | Xtandi |
| Janssen Biotech, INC. | $1,536.59 | 2019-2025 | Erleada, Akeega, Carvykti |
| Antares Pharma, INC. | $940.97 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Coloplast Corp | $867.36 | 2019-2025 | |
| Abbvie INC. | $801.77 | 2021-2025 | |
| Dendreon Pharmaceuticals LLC | $679.00 | 2019-2025 | Provenge |
| Pfizer INC. | $675.12 | 2019-2025 | |
| Procept Biorobotics Corporation | $469.96 | 2020-2025 | Aquabeam Robotic System |
| Allergan, INC. | $373.91 | 2019-2022 | |
| Olympus America INC. | $352.70 | 2020-2025 | Itind System, Bovie |
| Myovant Sciences INC. | $313.78 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $287.83 | 2020-2025 | Lynparza, Keytruda |
| Urovant Sciences INC | $287.48 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $277.86 | 2023-2025 | Gemtesa, Orgovyx |
| Laborie Medical Technologies Corp. | $277.01 | 2020-2024 | Optilume Bph Drug Coated Balloon Catheter, Goby |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Norris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.